All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @wyldstylefit on TikTok · 37s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @wyldstylefit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Testosterone and peptides. This is my current stack. All right, so first and foremost, I am not a doctor.
  2. 0:05I'm just going to give you my current stack, which is regulated by my doctor. I get my blood work done
  3. 0:09every six months. But first things first, testosterone. Mine's actually a blend of testosterone and
  4. 0:14nangelone, 140 milligrams of test and 60 milligrams of nangelone. Next, I got growth hormone. I take
  5. 0:20three IUs of growth before bed. This helps recovery and also helps with sleep. And then last but not
  6. 0:24least, Reddit TrueTied. This is a GLP3. It helps with the appetite suppressant and it's also
  7. 0:29helps with the hunger noise. So again, this is my current stack. I definitely recommend getting
  8. 0:33your blood work done before taking anything. Let's run it.

@wyldstylefit's TRT claims need more context

WyldStyleFit

TikTok creator

16.6K viewsWatch on TikTok

Quick answer

The stack described combines exogenous testosterone with nandrolone, recombinant human growth hormone, and a GLP-1 receptor agonist, a combination that introduces layered risks including HPA and HPG axis suppression, dyslipidemia, and insulin resistance that would typically require monitoring intervals shorter than six months under most endocrinology guidelines. Nandrolone is a Schedule III controlled substance with narrow FDA-approved indications, and its use in a custom testosterone blend for hormone optimization falls outside established clinical guidelines for male hypogonadism (Bhasin et al., 2018, JCEM). The misidentification of the GLP-1 medication as a 'GLP3' raises questions about how clearly the pharmacology of this regimen is understood by the person promoting it.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @wyldstylefit's TRT claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@wyldstylefit's TRT claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@wyldstylefit's TRT claims need more context" from WyldStyleFit. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The stack described combines exogenous testosterone with nandrolone, recombinant human growth hormone, and a GLP-1 receptor agonist, a combination that introduces layered risks including HPA and HPG axis suppression, dyslipidemia, and insulin resistance that would typically require monitoring intervals shorter than six months under most endocrinology guidelines.

The reason this review is not generic is the source wording and the canonical claim label "trt tiktok 7617126164016008479." In this clip, the useful excerpt is: "Testosterone and peptides." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Nandrolone is a Schedule III controlled substance.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The stack described combines exogenous testosterone with nandrolone, recombinant human growth hormone, and a GLP-1 receptor agonist, a combination that introduces layered risks including HPA and HPG axis suppression, dyslipidemia, and insulin resistance that would typically require monitoring intervals shorter than six months under most endocrinology guidelines.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The stack described combines exogenous testosterone with nandrolone, recombinant human growth hormone, and a GLP-1 receptor agonist, a combination that introduces layered risks including HPA and HPG axis suppression, dyslipidemia, and insulin resistance that would typically require monitoring intervals shorter than six months under most endocrinology guidelines. Nandrolone is a Schedule III controlled substance with narrow FDA-approved indications, and its use in a custom testosterone blend for hormone optimization falls outside established clinical guidelines for male hypogonadism (Bhasin et al., 2018, JCEM). The misidentification of the GLP-1 medication as a 'GLP3' raises questions about how clearly the pharmacology of this regimen is understood by the person promoting it.
  • GLP3 is not a real drug class. GLP-1 receptor agonists (semaglutide, tirzepatide) are the approved medications for appetite suppression, and the creator's terminology is factually incorrect.
  • Nandrolone is a Schedule III controlled substance. Its combination with testosterone in a custom blend for optimization is outside standard TRT guidelines and compounds cardiovascular and HPG suppression risks.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • GLP3 is not a real drug class. GLP-1 receptor agonists (semaglutide, tirzepatide) are the approved medications for appetite suppression, and the creator's terminology is factually incorrect.
  • Nandrolone is a Schedule III controlled substance. Its combination with testosterone in a custom blend for optimization is outside standard TRT guidelines and compounds cardiovascular and HPG suppression risks.
  • A 2020 JCEM study (Molitch et al.) found GH supplementation in non-deficient adults produced modest body composition benefits alongside real risks including insulin resistance and carpal tunnel syndrome.
  • Bhasin et al. (2018, JCEM) guidelines for testosterone therapy recommend monitoring lipids, hematocrit, and PSA, with intervals that often need to be shorter than six months when multiple hormonal agents are stacked.
  • Compounded versions of GLP-1 medications are not equivalent to FDA-approved branded drugs in terms of regulatory oversight, quality assurance, or studied efficacy.
  • Presenting a multi-drug hormonal stack without discussing individual risks or medical indications normalizes aggressive pharmacological regimens for viewers who may not have the same clinical context or supervision.
  • Physician oversight is a real safety factor, and the recommendation to get bloodwork before starting any hormonal regimen is genuinely good advice, but it does not substitute for understanding what each drug does and why.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @wyldstylefit actually say?

@wyldstylefit laid out what they call their current "stack": a blended injectable containing 140mg testosterone and 60mg nandrolone, 3 IUs of growth hormone taken before bed for recovery and sleep, and something they called "Reddit TrueTied," described as a "GLP3" that helps with appetite suppression and "hunger noise." They acknowledged they are not a doctor, said the regimen is supervised, and recommended getting bloodwork done before starting anything.

That last point deserves credit. The framing is relatively responsible compared to most TikTok hormone content. But several specific claims, and at least one outright misidentification of a drug class, need a closer look.

Does the science back this up?

The individual components here have legitimate medical applications, but the combination is aggressive, and the science on stacking them simultaneously is thin at best.

Testosterone replacement therapy (TRT) for diagnosed hypogonadism is well-supported. Nandrolone (likely nandrolone decanoate) has some clinical history, particularly in muscle-wasting conditions and anemia, but pairing it with testosterone in a custom blend for general "optimization" is not standard medical practice. A 2022 review in Andrology (Hackett et al.) notes that nandrolone's androgenic-to-anabolic ratio does reduce certain androgenic side effects compared to testosterone alone, but it also suppresses endogenous LH and FSH more aggressively and carries cardiovascular and lipid risks that compound with testosterone use.

Growth hormone (GH) at 3 IUs nightly sits at the higher end of what some anti-aging clinics prescribe. A 2020 study in The Journal of Clinical Endocrinology and Metabolism (Molitch et al.) found GH supplementation in non-deficient adults produced modest body composition changes alongside real risks: insulin resistance, edema, and carpal tunnel syndrome. The sleep and recovery claims have some mechanistic backing, since GH secretion peaks during slow-wave sleep, but taking exogenous GH before bed does not cleanly replicate that physiology.

What did they get wrong (or right)?

The most concrete error is calling their GLP-1 medication a "GLP3." There is no such drug class. GLP-1 receptor agonists, drugs like semaglutide or tirzepatide, are the medications used for appetite suppression and weight management. Tirzepatide acts on both GLP-1 and GIP receptors, which may have caused the confusion, but "GLP3" is not a recognized pharmacological category. The drug name "Reddit TrueTied" also does not correspond to any known branded or generic medication, suggesting either a significant mispronunciation or a compounded formulation being referred to informally.

What they got right: the recommendation to get bloodwork done is real advice. Six-month monitoring intervals are also consistent with some clinical guidelines for TRT, though more frequent monitoring is often recommended when stacking multiple hormonal agents (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism). The acknowledgment of physician oversight is meaningful, even if the stack itself raises questions.

What should you actually know?

If you watched this video and thought "I want that stack," here is what the evidence actually says about each component.

  • Testosterone therapy is FDA-approved for diagnosed hypogonadism. It is not approved as a general performance or wellness intervention, and access through regulated telehealth requires lab-confirmed low testosterone, not just a desire for optimization.
  • Nandrolone is a controlled substance with limited FDA-approved uses. Its inclusion in a custom testosterone blend for non-medical purposes sits outside standard of care and introduces compounding cardiovascular and hormonal suppression risks that are not trivial.
  • Growth hormone prescribed to adults without a confirmed GH deficiency is an off-label use. The FDA has not approved GH for anti-aging or athletic recovery in otherwise healthy adults. Risks scale with dose and duration.
  • GLP-1 receptor agonists like semaglutide are legitimate, increasingly prescribed medications for weight management and type 2 diabetes. They do reduce appetite and address what some patients describe as "food noise." But they require a prescription, and compounded versions are not equivalent to brand-name drugs in terms of regulatory oversight.

The broader issue: presenting a multi-drug hormonal stack to 16,000 viewers without discussing the risks of each agent, their interactions, or the specific medical conditions that justify their use is not responsible health content, regardless of how casually it is framed.

The bottom line

@wyldstylefit included some genuinely good advice, get bloodwork, work with a doctor. But the video misidentifies a drug class, casually normalizes a multi-hormone stack that most endocrinologists would not prescribe to a healthy adult, and provides zero context about why each drug is being used medically. That gap between "my doctor approved it" and "here is what the risks are" is exactly where health misinformation takes root.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

WyldStyleFit · TikTok creator

16.6K views on this video

@wyldstylefit's TRT claims need more context

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about glp3?

GLP3 is not a real drug class. GLP-1 receptor agonists (semaglutide, tirzepatide) are the approved medications for appetite suppression, and the creator's terminology is factually incorrect.

What does the video say about nandrolone?

Nandrolone is a Schedule III controlled substance. Its combination with testosterone in a custom blend for optimization is outside standard TRT guidelines and compounds cardiovascular and HPG suppression risks.

What does the video say about a 2020 jcem study (molitch et al.) found gh supplementation?

A 2020 JCEM study (Molitch et al.) found GH supplementation in non-deficient adults produced modest body composition benefits alongside real risks including insulin resistance and carpal tunnel syndrome.

What does the video say about bhasin et al. (2018, jcem) guidelines for testosterone therapy recommend?

Bhasin et al. (2018, JCEM) guidelines for testosterone therapy recommend monitoring lipids, hematocrit, and PSA, with intervals that often need to be shorter than six months when multiple hormonal agents are stacked.

What does the video say about compounded versions of glp-1 medications?

Compounded versions of GLP-1 medications are not equivalent to FDA-approved branded drugs in terms of regulatory oversight, quality assurance, or studied efficacy.

What does the video say about presenting a multi-drug hormonal stack without discussing individual risks?

Presenting a multi-drug hormonal stack without discussing individual risks or medical indications normalizes aggressive pharmacological regimens for viewers who may not have the same clinical context or supervision.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by WyldStyleFit, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.